161 related articles for article (PubMed ID: 16382337)
1. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
Monfort P; Muñoz MD; Felipo V
Metab Brain Dis; 2005 Dec; 20(4):265-74. PubMed ID: 16382337
[TBL] [Abstract][Full Text] [Related]
2. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
Monfort P; Muñoz MD; Felipo V
Neurobiol Dis; 2004 Feb; 15(1):1-10. PubMed ID: 14751765
[TBL] [Abstract][Full Text] [Related]
4. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
5. Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
Monfort P; Muñoz MD; Felipo V
J Neurochem; 2005 Aug; 94(4):934-42. PubMed ID: 16092938
[TBL] [Abstract][Full Text] [Related]
6. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
Monfort P; Felipo V
BMC Pharmacol; 2005 Jun; 5 Suppl 1(Suppl 1):P66. PubMed ID: 15969770
[No Abstract] [Full Text] [Related]
7. Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro.
Muñoz MD; Monfort P; Gaztelu JM; Felipo V
Neurochem Res; 2000 Apr; 25(4):437-41. PubMed ID: 10823575
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β impairs, and ibuprofen restores, the cGMP pathway, synaptic expression of AMPA receptors and long-term potentiation in the hippocampus.
Monfort P; Felipo V
J Alzheimers Dis; 2010; 22(3):795-809. PubMed ID: 20858955
[TBL] [Abstract][Full Text] [Related]
9. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
Zhuo M; Hu Y; Schultz C; Kandel ER; Hawkins RD
Nature; 1994 Apr; 368(6472):635-9. PubMed ID: 7908417
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in spatial learning, synaptic activity, and long-term potentiation in the hippocampus in rats: molecular mechanisms.
Monfort P; Gomez-Gimenez B; Llansola M; Felipo V
ACS Chem Neurosci; 2015 Aug; 6(8):1420-7. PubMed ID: 26098845
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
[TBL] [Abstract][Full Text] [Related]
12. The specific role of cGMP in hippocampal LTP.
Son H; Lu YF; Zhuo M; Arancio O; Kandel ER; Hawkins RD
Learn Mem; 1998; 5(3):231-45. PubMed ID: 10454367
[TBL] [Abstract][Full Text] [Related]
13. Postsynaptic NO/cGMP increases NMDA receptor currents via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.
Neitz A; Mergia E; Imbrosci B; Petrasch-Parwez E; Eysel UT; Koesling D; Mittmann T
Cereb Cortex; 2014 Jul; 24(7):1923-36. PubMed ID: 23448871
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
Puzzo D; Vitolo O; Trinchese F; Jacob JP; Palmeri A; Arancio O
J Neurosci; 2005 Jul; 25(29):6887-97. PubMed ID: 16033898
[TBL] [Abstract][Full Text] [Related]
15. Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade.
Mickley GA; Kenmuir CL; McMullen CA; Snyder A; Yocom AM; Likins-Fowler D; Valentine EL; Weber B; Biada JM
BMC Pharmacol; 2004 Oct; 4():28. PubMed ID: 15509306
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation.
Hawkins RD; Zhuo M; Arancio O
J Neurobiol; 1994 Jun; 25(6):652-65. PubMed ID: 8071665
[TBL] [Abstract][Full Text] [Related]
17. A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide.
Costa C; Tozzi A; Siliquini S; Galletti F; Cardaioli G; Tantucci M; Pisani F; Calabresi P
Neurobiol Dis; 2011 Nov; 44(2):185-91. PubMed ID: 21749921
[TBL] [Abstract][Full Text] [Related]
18. Activity-dependent long-term enhancement of transmitter release by presynaptic 3',5'-cyclic GMP in cultured hippocampal neurons.
Arancio O; Kandel ER; Hawkins RD
Nature; 1995 Jul; 376(6535):74-80. PubMed ID: 7596438
[TBL] [Abstract][Full Text] [Related]
19. Ammonia-mediated LTP inhibition: effects of NMDA receptor antagonists and L-carnitine.
Izumi Y; Izumi M; Matsukawa M; Funatsu M; Zorumski CF
Neurobiol Dis; 2005 Nov; 20(2):615-24. PubMed ID: 15935684
[TBL] [Abstract][Full Text] [Related]
20. Critical differences in magnitude and duration of N-methyl D-aspartate(NMDA) receptor activation between long-term potentiation (LTP) and long-term depression (LTD) induction.
Taniike N; Lu YF; Tomizawa K; Matsui H
Acta Med Okayama; 2008 Feb; 62(1):21-8. PubMed ID: 18323868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
